Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

aTYR PHARMA (ATYR) Return on Assets (2019 - 2025)

Historic Return on Assets for aTYR PHARMA (ATYR) over the last 7 years, with Q3 2025 value amounting to 0.76%.

  • aTYR PHARMA's Return on Assets fell 700.0% to 0.76% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.76%, marking a year-over-year decrease of 700.0%. This contributed to the annual value of 0.62% for FY2024, which is 1200.0% down from last year.
  • According to the latest figures from Q3 2025, aTYR PHARMA's Return on Assets is 0.76%, which was down 700.0% from 0.7% recorded in Q2 2025.
  • In the past 5 years, aTYR PHARMA's Return on Assets registered a high of 0.06% during Q3 2021, and its lowest value of 0.76% during Q3 2025.
  • Moreover, its 5-year median value for Return on Assets was 0.37% (2021), whereas its average is 0.42%.
  • As far as peak fluctuations go, aTYR PHARMA's Return on Assets surged by 3200bps in 2021, and later tumbled by -3300bps in 2024.
  • aTYR PHARMA's Return on Assets (Quarter) stood at 0.06% in 2021, then crashed by -517bps to 0.35% in 2022, then decreased by -27bps to 0.45% in 2023, then tumbled by -61bps to 0.72% in 2024, then decreased by -5bps to 0.76% in 2025.
  • Its Return on Assets was 0.76% in Q3 2025, compared to 0.7% in Q2 2025 and 0.69% in Q1 2025.